ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer

January 25, 2008

Is OMB Paying More Attention To Bypass Budget? NCI Awaits FY 1984 Figure

November 26, 1982

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

Minority CCOP Applications Not Yet Reviewed

December 15, 1989